Clinical Trials Browser

Phase 3 × Terminated × Hepatitis C, Chronic × Clear all

NCT02319200 2017-01-11

METFOVIR

Phase 3 Terminated

Gastrointestinal

Death, Fibrosis, Carcinoma, Hepatocellular, Hepatitis C, Chronic